{"id":2360,"date":"2017-10-02T22:17:18","date_gmt":"2017-10-02T21:17:18","guid":{"rendered":"http:\/\/www.epilepsija.hr\/?p=2360"},"modified":"2017-10-02T22:17:18","modified_gmt":"2017-10-02T21:17:18","slug":"anketa-o-prijavljivanju-nuspojava-lijekova","status":"publish","type":"post","link":"https:\/\/www.epilepsija.hr\/?p=2360","title":{"rendered":"ANKETA O PRIJAVLJIVANJU NUSPOJAVA LIJEKOVA"},"content":{"rendered":"<p>Europska agencija za lijekove (<em>European Medicines Agency-EMA<\/em>) provodi anketu o prijavljivanju nuspojava lijekova i na\u010dinu na koji ih bolesnici\/potro\u0161a\u010di i zdravstveni radnici prijavljuju. Rezultate \u0107e analizirati EMA, dok \u0107e Europskoj komisiji (Glavna uprava za zdravlje i sigurnost hrane) biti poslano izvje\u0161\u0107e s prikupljenim zbirnim podacima koji \u0107e se dalje javno distribuirati.<\/p>\n<p>Pozivamo vas sve da sudjelujete u ovoj anketi koja sadr\u017ei 10 pitanja (za ispunjavanje je potrebno 5-10 minuta). Anketa je dostupna na svim slu\u017ebenim europskim jezicima te tako i na hrvatskom jeziku.<\/p>\n<p>Anketi mo\u017eete pristupiti na slijede\u0107oj poveznici do <strong>9. listopada 2017. godine<\/strong>:<\/p>\n<p><a href=\"https:\/\/ec.europa.eu\/eusurvey\/runner\/EMA-survey-on-reporting-adverse-drug-reactions\"><u>https:\/\/ec.europa.eu\/eusurvey\/runner\/EMA-survey-on-reporting-adverse-drug-reactions<\/u><\/a><\/p>\n<p><a href=\"http:\/\/www.epilepsija.hr\/wp-content\/uploads\/image005.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2359 alignnone\" src=\"http:\/\/www.epilepsija.hr\/wp-content\/uploads\/image005.jpg\" alt=\"image005\" width=\"362\" height=\"204\" srcset=\"https:\/\/www.epilepsija.hr\/wp-content\/uploads\/image005.jpg 362w, https:\/\/www.epilepsija.hr\/wp-content\/uploads\/image005-300x169.jpg 300w\" sizes=\"(max-width: 362px) 100vw, 362px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Europska agencija za lijekove (European Medicines Agency-EMA) provodi anketu o prijavljivanju nuspojava lijekova i na\u010dinu na koji ih bolesnici\/potro\u0161a\u010di i zdravstveni radnici prijavljuju. Rezultate \u0107e analizirati EMA, dok \u0107e Europskoj komisiji (Glavna uprava za zdravlje i sigurnost hrane) biti poslano izvje\u0161\u0107e s prikupljenim zbirnim podacima koji \u0107e se dalje javno distribuirati. Pozivamo vas sve da &hellip; <a href=\"https:\/\/www.epilepsija.hr\/?p=2360\" class=\"more-link\">Nastavi \u010ditati <span class=\"screen-reader-text\">ANKETA O PRIJAVLJIVANJU NUSPOJAVA LIJEKOVA<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=\/wp\/v2\/posts\/2360"}],"collection":[{"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2360"}],"version-history":[{"count":1,"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=\/wp\/v2\/posts\/2360\/revisions"}],"predecessor-version":[{"id":2361,"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=\/wp\/v2\/posts\/2360\/revisions\/2361"}],"wp:attachment":[{"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.epilepsija.hr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}